AU6214086A - Monoclonal antibodies against tumour-associated glycoproteins, a process for their preparation and their use - Google Patents
Monoclonal antibodies against tumour-associated glycoproteins, a process for their preparation and their useInfo
- Publication number
- AU6214086A AU6214086A AU62140/86A AU6214086A AU6214086A AU 6214086 A AU6214086 A AU 6214086A AU 62140/86 A AU62140/86 A AU 62140/86A AU 6214086 A AU6214086 A AU 6214086A AU 6214086 A AU6214086 A AU 6214086A
- Authority
- AU
- Australia
- Prior art keywords
- preparation
- monoclonal antibodies
- antibodies against
- against tumour
- associated glycoproteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6851—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19853531301 DE3531301A1 (en) | 1985-09-02 | 1985-09-02 | MONOCLONAL ANTIBODIES AGAINST TUMOR ASSOCIATED GLYCOPROTEINS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
DE3531301 | 1985-09-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU6214086A true AU6214086A (en) | 1987-03-05 |
AU611381B2 AU611381B2 (en) | 1991-06-13 |
Family
ID=6279944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU62140/86A Ceased AU611381B2 (en) | 1985-09-02 | 1986-09-01 | Monoclonal antibodies against tumour-associated glycoproteins, a process for their preparation and their use |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0213581A3 (en) |
JP (1) | JP2526217B2 (en) |
AU (1) | AU611381B2 (en) |
DE (1) | DE3531301A1 (en) |
DK (1) | DK415586A (en) |
ES (1) | ES2000615A6 (en) |
GR (1) | GR862238B (en) |
MX (1) | MX3601A (en) |
PT (1) | PT83285B (en) |
ZA (1) | ZA866614B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU601379B2 (en) * | 1985-11-07 | 1990-09-13 | Trustees Of Columbia University In The City Of New York, The | Antigen indicative of human breast cancer and assays based thereon |
AU619232B2 (en) * | 1988-01-05 | 1992-01-23 | Buchegger, Franz Dr. | Novel antibodies |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3629640A1 (en) * | 1986-08-30 | 1988-03-03 | Behringwerke Ag | USE OF MONOCLONAL ANTIBODIES FOR THE TREATMENT OF TUMORS |
DE3584280D1 (en) * | 1984-10-26 | 1991-11-07 | Wakunaga Seiyaku Kk | MONOCLONAL ANTIBODY AGAINST HUMAN CANCER. |
US4926869A (en) * | 1986-01-16 | 1990-05-22 | The General Hospital Corporation | Method for the diagnosis and treatment of inflammation |
DE3825615A1 (en) * | 1988-07-28 | 1990-02-01 | Behringwerke Ag | ANTIGENT CONSTRUCTS OF "MAJOR HISTOCOMPATIBILITY COMPLEX" CLASS I ANTIGENS WITH SPECIFIC CARRIER MOLECULES, THEIR PRODUCTION AND USE |
JPH0266456A (en) * | 1988-08-31 | 1990-03-06 | Saikin Kagaku Kenkyusho:Kk | Primary diagnostic method for disease animal and diagnostic reagent used therein and its production |
DE3909799A1 (en) | 1989-03-24 | 1990-09-27 | Behringwerke Ag | MONOCLONAL ANTIBODIES (MAK) AGAINST TUMOR ASSOCIATED ANTIGENS, THEIR PRODUCTION AND USE |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3329184A1 (en) * | 1983-08-12 | 1985-02-21 | Behringwerke Ag, 3550 Marburg | MONOCLONAL ANTIBODIES WITH SPECIFICITY FOR MEMBRANE-ASSOCIATED ANTIGENS |
DE3416774A1 (en) * | 1984-05-07 | 1985-11-14 | Behringwerke Ag, 3550 Marburg | MONOCLONAL ANTIBODIES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
US4585742A (en) * | 1983-12-14 | 1986-04-29 | Dana-Farber Cancer Institute, Inc. | Monoclonal antibody with specificity to human small cell carcinoma and use thereof |
DK276185D0 (en) * | 1984-11-09 | 1985-06-19 | Novo Industri As | MONOCLONAL ANTIBODIES, METHOD OF PREPARING THESE AND THEIR DIAGNOSTIC USES |
JPS61258173A (en) * | 1985-05-10 | 1986-11-15 | Akira Taniuchi | Monoclonal antibody and production and application thereof |
US5185432A (en) * | 1986-02-26 | 1993-02-09 | Oncogen | Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas |
-
1985
- 1985-09-02 DE DE19853531301 patent/DE3531301A1/en not_active Withdrawn
-
1986
- 1986-08-23 EP EP86111708A patent/EP0213581A3/en not_active Withdrawn
- 1986-08-29 MX MX360186A patent/MX3601A/en unknown
- 1986-09-01 ES ES8601533A patent/ES2000615A6/en not_active Expired
- 1986-09-01 GR GR862238A patent/GR862238B/en unknown
- 1986-09-01 PT PT83285A patent/PT83285B/en not_active IP Right Cessation
- 1986-09-01 ZA ZA866614A patent/ZA866614B/en unknown
- 1986-09-01 JP JP61203909A patent/JP2526217B2/en not_active Expired - Lifetime
- 1986-09-01 DK DK415586A patent/DK415586A/en not_active Application Discontinuation
- 1986-09-01 AU AU62140/86A patent/AU611381B2/en not_active Ceased
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU601379B2 (en) * | 1985-11-07 | 1990-09-13 | Trustees Of Columbia University In The City Of New York, The | Antigen indicative of human breast cancer and assays based thereon |
AU619232B2 (en) * | 1988-01-05 | 1992-01-23 | Buchegger, Franz Dr. | Novel antibodies |
Also Published As
Publication number | Publication date |
---|---|
PT83285B (en) | 1989-05-12 |
DK415586A (en) | 1987-03-03 |
DK415586D0 (en) | 1986-09-01 |
DE3531301A1 (en) | 1987-03-05 |
JP2526217B2 (en) | 1996-08-21 |
ZA866614B (en) | 1987-04-29 |
AU611381B2 (en) | 1991-06-13 |
ES2000615A6 (en) | 1988-03-01 |
EP0213581A2 (en) | 1987-03-11 |
JPS6269997A (en) | 1987-03-31 |
MX3601A (en) | 1993-05-01 |
PT83285A (en) | 1986-10-01 |
EP0213581A3 (en) | 1988-05-25 |
GR862238B (en) | 1986-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4589289A (en) | Synthetic antigens, a process for the preparation thereof and the use thereof | |
AU589635B2 (en) | Antibody conjugates | |
AU4154385A (en) | Antibodies, manufacture and use | |
AU6182286A (en) | Composite fiber and process for preparation thereof | |
AU4493685A (en) | Polyclonal antibodies, preparation and use | |
AU6686686A (en) | Aerochocolates and process for preparing the same | |
HUT38391A (en) | Process for preparing new monoclonal antibodies against glycoconjugates and for the utilization thereof | |
AU1944088A (en) | Nuclear antigen la | |
AU3330689A (en) | Monoclonal antibodies | |
GB2184127B (en) | Immobilized c-peptide antibody, and the preparation and use thereof | |
AU6214086A (en) | Monoclonal antibodies against tumour-associated glycoproteins, a process for their preparation and their use | |
GB8318575D0 (en) | Antibody preparations | |
AU1374088A (en) | Beauty preparations having anti-fading effect and a process for preparing the same | |
AU569816B2 (en) | Monoclonal anti-alpha-amylase antibody | |
AU4174789A (en) | Hybrid monoclonal antibodies, their production and use | |
IL83342A0 (en) | Monoclonal antibodies,their preparation and their use | |
AU590731B2 (en) | Estriol-3-sulfate protein conjugates and antibodies thereto | |
GB8506373D0 (en) | Antigens antibodies | |
AU1042488A (en) | Bilirubin antigen, monoclonal antibody therefor, process for their preparation, and their use | |
ZA842352B (en) | Gonadoliberin derivatives containing a beta-aspartyl group,a process for the preparation thereof and pharmaceutical preparations containing them | |
AU5736286A (en) | Rotavirus antigens | |
AU7588787A (en) | Preparation for immunoassay and method for producing the preparation | |
AU618720B2 (en) | Monoclonal antibodies | |
GR862884B (en) | Monoclonal antibodies cross reactive and cross-protective against p aeruginosa serotypes | |
AU585069B2 (en) | Alkenylazoles, a process for their preparation and their use |